Original Source(s)
Nomogram Advances Retinopathy Screening
June 1, 2026
Related Content
Investigational OCTA Devices Show Promise in Diabetic Disease Assessment
At Retina World Congress, Patricio G. Schlottmann, MD, discussed investigational widefield OCTA platforms made by Chinese company TowardPi Medical.
May 14, 2026
-
2 min